-
Biphenyl amide p38 kinase inhibitors 1: Discovery and binding mode.
GlaxoSmithKline R&D, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK.
The biphenyl amides (BPAs) are a novel series of p38 MAP kinase inhibitors. The discovery of the series through structure-based focused screening is described, and the binding mode of the compounds is explained with reference to X-ray crystal structures.
PMID: 18006306 [PubMed - indexed for MEDLINE]
-
Structures reported by this article